Susan Cherry-Casey
Nurse Practitioner · Union, SCNPI 1619412079
Payments from drug & device makers
Across 49 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$193
- Novartis$91
- Johnson & Johnson$63
- Amgen$50
- Pfizer$50
- Merck$37
- plus $365 from 15 others
What the payments were for
- Food & beverage$848100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $193 |
| Novartis | 5 | $91 |
| Johnson & Johnson | 4 | $63 |
| Amgen | 3 | $50 |
| Pfizer | 3 | $50 |
| Merck | 2 | $37 |
| AstraZeneca | 2 | $35 |
| Abiomed | 1 | $35 |
| Exact Sciences | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| GSK | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $23 |
| Atricure, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Cranial Technologies, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Bayer | 1 | $13 |
| Novo Nordisk | 1 | $13 |
How this compares
$848 in reported general payments places this provider in the 75th percentile of 1,346 nurse practitioner providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $13,962 |
| Repatha SureclickEvolocumab | 14 | $13,033 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $2,285 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,252 |
| Montelukast Sodium | 56 | $1,036 |
| Atorvastatin Calcium | 113 | $945 |
| Fluticasone Propionate | 42 | $740 |
| Amlodipine Besylate | 102 | $523 |
| Omeprazole | 24 | $492 |
| Pantoprazole Sodium | 44 | $449 |
| Losartan Potassium | 54 | $412 |
| Potassium Chloride | 33 | $364 |
| Gabapentin | 23 | $348 |
| Carvedilol | 37 | $324 |
| Levocetirizine Dihydrochloride | 26 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $13 | $13,96211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Union
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
- Gail KirbyGreer$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.